GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets

Show full item record



Permalink

http://hdl.handle.net/10138/165640

Citation

Mpindi , J P , Sara , H , Haapa-Paananen , S , Kilpinen , S , Pisto , T , Bucher , E , Ojala , K , Iljin , K , Vainio , P , Bjorkman , M , Gupta , S , Kohonen , P , Nees , M & Kallioniemi , O 2011 , ' GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets ' PLoS One , vol. 6 , no. 2 , pp. Article Number: e17259 . DOI: 10.1371/journal.pone.0017259

Title: GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets
Author: Mpindi, John Patrick; Sara, Henri; Haapa-Paananen, Saija; Kilpinen, Sami; Pisto, Tommi; Bucher, Elmar; Ojala, Kalle; Iljin, Kristiina; Vainio, Paula; Bjorkman, Mari; Gupta, Santosh; Kohonen, Pekka; Nees, Matthias; Kallioniemi, Olli
Other contributor: University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, BIOTIETEIDEN LAITOS (-2009)
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
Date: 2011-02-18
Language: eng
Number of pages: 12
Belongs to series: PLoS One
ISSN: 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0017259
URI: http://hdl.handle.net/10138/165640
Abstract: Background Meta-analysis of gene expression microarray datasets presents significant challenges for statistical analysis. We developed and validated a new bioinformatic method for the identification of genes upregulated in subsets of samples of a given tumour type (‘outlier genes’), a hallmark of potential oncogenes. Methodology A new statistical method (the gene tissue index, GTI) was developed by modifying and adapting algorithms originally developed for statistical problems in economics. We compared the potential of the GTI to detect outlier genes in meta-datasets with four previously defined statistical methods, COPA, the OS statistic, the t-test and ORT, using simulated data. We demonstrated that the GTI performed equally well to existing methods in a single study simulation. Next, we evaluated the performance of the GTI in the analysis of combined Affymetrix gene expression data from several published studies covering 392 normal samples of tissue from the central nervous system, 74 astrocytomas, and 353 glioblastomas. According to the results, the GTI was better able than most of the previous methods to identify known oncogenic outlier genes. In addition, the GTI identified 29 novel outlier genes in glioblastomas, including TYMS and CDKN2A. The over-expression of these genes was validated in vivo by immunohistochemical staining data from clinical glioblastoma samples. Immunohistochemical data were available for 65% (19 of 29) of these genes, and 17 of these 19 genes (90%) showed a typical outlier staining pattern. Furthermore, raltitrexed, a specific inhibitor of TYMS used in the therapy of tumour types other than glioblastoma, also effectively blocked cell proliferation in glioblastoma cell lines, thus highlighting this outlier gene candidate as a potential therapeutic target. Conclusions/Significance Taken together, these results support the GTI as a novel approach to identify potential oncogene outliers and drug targets. The algorithm is implemented in an R package (Text S1).
Subject: NEWLY-DIAGNOSED GLIOBLASTOMA
PHASE-II
CANCER
IMMUNOHISTOCHEMISTRY
CHEMOTHERAPY
GEMCITABINE
GENERATIONS
REGRESSION
ARRAYS
MAP
3111 Biomedicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
journal.pone.0017259.PDF 1.554Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record